Conavi Medical Corp. (TSXV:CNVI)
Canada flag Canada · Delayed Price · Currency is CAD
0.1500
-0.0050 (-3.23%)
At close: Sep 11, 2026

Conavi Medical Financials Overview

Millions CAD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22
Revenue
0.859.122.162.362.7
Revenue Growth
-90.85%322.12%-8.59%-12.44%-
Gross Profit
0.817.630.051.41.69
Operating Income
-21.2-14.85-26.23-21.63-10.28
Net Income
-20.62-20.52-43.62-26.09-11.87
Earnings Per Share
-0.23-0.36-7.08-4.24-1.93
EPS Growth
-----

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22
Asia
0.849.122.072.292.58
Canada
--00.030.04
North America (Excluding Canada)
-0.010.080.050.08
Total
0.859.122.162.362.7

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22
Cash & Investments
0.885.840.4414.174.59
Total Debt
1819.9183.1854.4131.88
Net Cash (Debt)
-17.12-14.07-82.74-40.24-27.29
Net Cash Growth
-----
Net Cash Per Share
-0.19-0.24-13.43-6.54-4.43

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22
Operating Cash Flow
-18.66-25.1-20.15-19.98-8.85
Capital Expenditures
-0.5-0.07-0.58-0.69-0.93
Free Cash Flow
-19.16-25.17-20.72-20.66-9.78
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22
Gross Margin
96.09%83.61%2.45%59.22%62.67%
Operating Margin
-2508.99%-162.81%-1213.93%-914.76%-380.89%
Pretax Margin
-2439.76%-224.91%-2018.28%-1103.51%-439.52%
Profit Margin
-2439.76%-224.91%-2018.28%-1103.51%-439.52%
FCF Margin
-2267.10%-275.96%-958.95%-874.07%-362.22%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Sep '25 Sep '24 Sep '23 Sep '22
PS Ratio
24.505.64---